Cotherix

CoTherix, Inc. operates as a development stage company that engages in biopharmaceutical operations.

Business Model:

Revenue: $0

Employees: 51-200

Rankings

Detailed Cotherix Information

Cotherix was acquired by Actelion Pharmaceuticals.
The acquisition happend on 2006-11-20.
Details of the transaction were not public

Geographic Data

Cotherix headquarters map

Address:

City: San Francisco

State: California

Zip:

Country: United States

Financial Info

Stage:

series c

Raised Last:

$55M

Raised Total:

$55M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Cotherix is a biopharmaceutical company focused on licensing, developing and commercializing therapeutic products for the treatment of cardiopulmonary and other chronic diseases. Ventavis, our lead product candidate, is an inhaled formulation of iloprost.

Contact Phone:

Contact Email:

Cotherix went public on 10/15/2004 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
10/15/2004

Ticker Symbol:
CTRX

IPO Price:
$6/share

Amount Raised:
$30M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research